Table 5.
Comparison of the treatment between the Han (n = 287) and Uygur group (n = 264) of BC patients
| Variables | Han (n (%)) | Uygur (n (%)) | X 2 (df) | P-value |
|---|---|---|---|---|
| Operation | 2.111 (1) | 0.146 | ||
| breast conserving operation | 36 (12.5) | 23 (8.7) | ||
| mastectomy | 251 (87.5) | 241 (91.3) | ||
| Method of chemotherapy | 0.878 (1) | 0.349 | ||
| unique | 260 (90.6) | 245 (92.8) | ||
| changed | 27 (9.4) | 19 (7.2) | ||
| Chemotherapy regimens | 19.628 (3) | < 0.001 | ||
| methotrexate-based | 16 (5.6) | 39 (14.8) | ||
| anthracycline-based | 112 (39) | 89 (33.7) | ||
| vinorelbine-based | 71 (24.7) | 41 (15.5) | ||
| taxane-based | 88 (30.7) | 95 (36) | ||
| Number of cycle | 6.508 (1) | 0.011 | ||
| ≤ 4 | 33 (11.5) | 51 (19.3) | ||
| ≥ 5 | 254 (88.5) | 213 (80.7) | ||
| radiotherapy | 9.502 (1) | 0.009 | ||
| yes | 100 (34.8) | 125 (47.3) | ||
| no | 187 (65.2) | 139 (52.7) |
Abbreviation: BC breast cancer.